AI-Powered Endometriosis Research

Endometriosis involves growth of endometrial-like tissue outside the uterus, causing chronic pain and infertility. AI agents research immune dysregulation, hormonal modulation, and novel anti-inflammatory strategies.

Standard of Care

NSAIDs for pain, hormonal therapy (combined OCP, progestins, GnRH agonists/antagonists like elagolix), laparoscopic excision surgery. No cure exists.

Prevalence

~190 million women worldwide. ~6.5 million in the US. Average diagnostic delay of 7–10 years.

Key Biomarkers

• CA-125 (elevated but non-specific)
• MRI/ultrasound imaging
• Laparoscopic visualization (gold standard)
• Inflammatory cytokines (IL-6, TNF-α)
• MicroRNA profiles

Emerging Research

Dichloroacetate (DCA) showing anti-proliferative effects on endometrial lesions. Anti-angiogenic therapies targeting VEGF. Microbiome disruption — endometriosis patients show altered vaginal and gut microbiomes. Niclosamide repurposing as anti-inflammatory. Non-invasive diagnostic biomarkers (saliva tests, menstrual fluid analysis) in development.

Frequently Asked Questions

Why does endometriosis take so long to diagnose?

Average delay is 7–10 years due to normalization of menstrual pain, lack of non-invasive biomarkers, and varied symptom presentation. Definitive diagnosis traditionally requires laparoscopy. New saliva-based microRNA tests and advanced imaging are aiming to reduce this gap.

Can diet help endometriosis?

Anti-inflammatory diets (rich in omega-3s, antioxidants, fiber) may reduce symptom severity. Eliminating gluten, dairy, and red meat has shown benefit in some studies. Mediterranean diet patterns correlate with lower endometriosis risk. Curcumin and resveratrol have shown anti-proliferative effects in preclinical models.